treatment of solitary rectal ulcer syndrome

Reading File

Finding Sources

Searching PubMed

"solitary rectal ulcer syndrome" AND treatment

Finding Sources

Reading File

Reading Article

PMID: 38957108

Reading File

Finding Sources

Reading File

I now have comprehensive information from multiple authoritative sources. Let me compile a thorough answer.

Solitary Rectal Ulcer Syndrome (SRUS) — Treatment

SRUS is a chronic, benign disorder characterized by rectal ulceration (or erythema/polypoid lesions) arising from disordered defecation, rectal mucosal prolapse, and chronic ischemia. There are no published formal guidelines, so management is tailored to symptom severity and underlying pathology. Treatment is broadly organized as conservative, biofeedback, endoscopic, and surgical.

1. Conservative (First-Line for Mild–Moderate Disease)

Measure	Details
High-fiber diet & bulking agents	Increases stool bulk, reduces straining. Fiber supplementation alone achieved complete ulcer healing in 15/21 patients over ~10.5 months in one study.
Bowel habit retraining	Patients instructed to resist the urge to strain; avoid prolonged toilet sitting; avoid digital self-disimpaction.
Laxatives/stool softeners	Bulk-forming or osmotic laxatives to normalize defecation.
Avoid inciting behaviors	Eliminate ergotamine suppositories, NSAIDs, and other aggravating agents when identified.

Asymptomatic patients may not require any treatment, and spontaneous resolution occurs in some.

Yamada's Textbook of Gastroenterology, 7th ed., p. 1442

Sleisenger and Fordtran's GI and Liver Disease, p. 2652

2. Topical / Local Agents

Agent	Evidence
Sucralfate enemas	Small case series show benefit; thought to promote mucosal healing.
Human fibrin sealant / fibrin glue	Applied to ulcer bed; stimulates angiogenesis and accelerates healing — described in small series.
Topical glucocorticoids	Not effective — largely ineffectual.
Aminosalicylates (mesalamine enemas)	Not effective — ineffectual in SRUS.

Sleisenger and Fordtran's, p. 2652

Yamada's, p. 1442

3. Argon Plasma Coagulation (APC)

A randomized controlled trial showed that APC not only controlled rectal bleeding but also led to healing of the rectal ulcer. This has been reaffirmed in multiple subsequent studies. APC is particularly useful for hemorrhagic SRUS refractory to conservative measures.

Sleisenger and Fordtran's, p. 2652

4. Biofeedback (Behavioral Therapy)

Biofeedback is considered first-line therapy for patients with underlying pelvic floor dysfunction or dyssynergic defecation. It corrects paradoxical puborectalis contraction and reduces excessive straining.

Outcomes:

Clinical improvement in ~75% of patients
Ulcer healing in ~31%
Significant improvement in rectal mucosal blood flow in subjective responders
12/16 patients in one study reported subjective improvement
Benefits may deteriorate over time; however, 50% of early responders maintained benefit at a median of 3 years
Biofeedback before or after surgery reduces recurrence rates compared to no biofeedback

Sleisenger and Fordtran's, p. 2652

Yamada's, p. 1442

Schwartz's Principles of Surgery, 11th ed., p. 1333

5. Surgical Treatment (Refractory Cases)

Surgery is reserved for patients who fail conservative management and biofeedback, particularly those with demonstrable prolapse. Preoperative defecography is recommended to identify the underlying anatomy.

Procedures Used:

Procedure	Indication / Notes
Laparoscopic/abdominal rectopexy	Most commonly performed; corrects internal intussusception or rectal prolapse underlying SRUS. Satisfactory outcomes in ~55% at median 90 months follow-up.
Resection rectopexy (± sigmoid resection)	For patients with mucosal intussusception or overt rectal prolapse; sigmoid resection added to reduce constipation.
Ventral mesh rectopexy (laparoscopic)	Non-resectional; anterior rectal dissection with mesh anchored to sacral promontory — increasingly used.
Perineal procedures (mucosal resection / perineal rectosigmoidectomy)	For external prolapse or high-risk patients; higher recurrence.
Low anterior resection	Rarely required.
Colostomy	~30% of surgical patients ultimately require a stoma for persistent constipation or failed surgery — a significant caveat.
Local excision	Not recommended — does not address underlying pathophysiology; high recurrence.

Surgical outcomes: 55–60% long-term satisfaction after surgery for SRUS with rectal prolapse; ~30% eventually need a stoma. A 2024 network meta-analysis (22 studies, 911 patients) found surgery had the highest ulcer healing rate at 70.5% (95% CI 0.57–0.83), and was superior to both medical therapy and biofeedback (OR 0.09 and 0.14 respectively).

Sleisenger and Fordtran's, p. 2652

Yamada's, p. 1442

Schwartz's Principles of Surgery, p. 1333–1334

Gaj et al., Colorectal Dis 2024 [PMID: 38957108]

Treatment Algorithm Summary

SRUS Diagnosed
    │
    ├─► Asymptomatic → Observe (may resolve spontaneously)
    │
    ├─► Mild symptoms → High-fiber diet + bowel habit retraining + laxatives
    │       └─► If bleeding prominent → Add APC
    │
    ├─► Pelvic floor dysfunction → Biofeedback (first-line)
    │       └─► Topical: Sucralfate enemas / fibrin glue (adjunct)
    │
    └─► Refractory / Associated prolapse → Surgery
            ├─► Internal intussusception → Rectopexy ± sigmoid resection
            ├─► External prolapse → Rectopexy or perineal procedure
            └─► Failed surgery / refractory constipation → Consider colostomy

Key Points

Topical steroids and mesalamine are ineffective and should not be used.
Biofeedback is first-line when pelvic floor dyssynergia is present and is beneficial both pre- and post-operatively.
APC is the most evidence-backed endoscopic intervention for hemorrhagic or refractory ulcers.
Surgery has the highest ulcer healing rate but carries significant long-term morbidity (~30% require stoma).
The absence of formal guidelines means treatment must be individualized based on symptoms, underlying anatomy (defecography), and response to conservative measures.

This is a shared conversation. Sign in to Orris to start your own chat.